An overview of gene therapy approaches to neurological malignancies

Area of Science:

• Oncology
• Genetics
• Gene Therapy

Background:

• Tumorigenesis arises from somatic and genetic alterations, leading to uncontrolled cell proliferation.
• Gene therapy is being explored as a treatment for genetic diseases, including cancers.
• Current gene therapy strategies leverage viral vectors for targeted cancer treatment.

Purpose of the Study:

• To review current gene therapy strategies for cancer treatment.
• To discuss the potential and limitations of gene therapy in oncology.
• To highlight emerging approaches like suicide gene therapy and oncolytic virotherapy.

Main Methods:

• Utilizing retroviruses for 'suicide' gene delivery in neurological malignancies.
• Employing adenoviruses with E1B deletions for p53-deficient tumors.
• Developing anti-angiogenesis strategies, including blockade of angiogenesis inducers.

Main Results:

• Retroviral suicide gene therapy has shown success in treating neurological cancers.
• Adenoviruses targeting p53-deficient tumors present a novel therapeutic avenue.
• Anti-angiogenesis strategies show encouraging results in preclinical models.

Conclusions:

• Gene therapy holds significant promise for cancer treatment, with various viral-based strategies under investigation.
• While progress has been made, particularly in specific cancer types, gene therapy has not yet achieved permanent cures for human genetic diseases.
• Further research and cautious clinical application are warranted given the current limitations and ongoing developments in the field.